NCT00014677View on ClinicalTrials.gov

NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2001

Primary Completion Date

September 30, 2002

Study Completion Date

July 31, 2008

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

interleukin-4 PE38KDEL cytotoxin

PROCEDURE

conventional surgery

Trial Locations (4)

30322

Emory University Hospital - Atlanta, Atlanta

92037

UCSD Thornton Hospital, La Jolla

63110-0250

St. Louis University Health Sciences Center, St Louis

28207-1830

Charlotte Neurosurgical Associates, Charlotte

Sponsors
All Listed Sponsors
lead

Neurocrine Biosciences

INDUSTRY